赛诺菲宣布，已完成将其消费者健康业务欧彼乐50.0%的控股权出售予Clayton, Dubilier & Rice（以下简称CD&R）的交易。赛诺菲仍保留欧彼乐48.2%的重要股权。

智通财经获悉，赛诺菲(SNY.US)周一表示，已就将其消费者保健业务Opella 50%的控股权出售给美国私募股权公司Clayton Dubilier & Rice进入排他性谈判。

赛诺菲为法国最大制药厂，它曾在上周表示，正在与CD&R就出售Opella 50%的控股权进行谈判；当时引起政府的批评，认为可能失去战略资产。 据法国 ...

Claims that Cornerstone Building Brands Inc.‘s board manipulated the company’s forecasts amid pressure from Clayton, Dubilier ...

The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...

Advt The open offer has been triggered by Sanofi and CD&R entering into exclusive negotiations for the potential sale and purchase of a 50 per cent controlling stake in Opella, Sanofi's consumer ...

A group including CD&R and existing lenders, including HPS Investment Partners, agreed to a deal that will inject $225 million of new equity into Vialto and slash around $700 million of its ...

"Walt is recognized as an industry leader in financial services, having played a pivotal role in the substantial growth of one of America's most significant companies," said CD&R Partner David ...

NEW YORK, April 8, 2025 /PRNewswire/ -- CD&R (or the "Firm") announced today the appointment of Michael Harrington as Risk Director, a newly created position that will provide strategic risk ...

NEW YORK, March 31, 2025 /PRNewswire/ -- CD&R (or the "Firm") today announced the appointment of Walt Bettinger, former chief executive of The Charles Schwab Corporation ("Schwab"), as Senior ...